|
BTBD7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.34599999999752E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.955500E-04 |
| Normal-vs-Stage2 |
8.428500E-02 |
| Normal-vs-Stage3 |
1.942630E-01 |
| Normal-vs-Stage4 |
9.687000E-01 |
| Stage1-vs-Stage2 |
7.606600E-01 |
| Stage1-vs-Stage3 |
6.617200E-01 |
| Stage1-vs-Stage4 |
2.094800E-01 |
| Stage2-vs-Stage3 |
6.062000E-01 |
| Stage2-vs-Stage4 |
2.128200E-01 |
| Stage3-vs-Stage4 |
4.095800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.975180E-04 |
| Normal-vs-AfricanAmerican |
5.383500E-03 |
| Normal-vs-Asian |
5.962200E-01 |
| Caucasian-vs-AfricanAmerican |
9.259400E-01 |
| Caucasian-vs-Asian |
4.824000E-01 |
| AfricanAmerican-vs-Asian |
4.410400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.953000E-04 |
| Normal-vs-Female |
2.428700E-04 |
| Male-vs-Female |
2.183600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.401390E-01 |
| Normal-vs-Extreme_Weight |
1.806120E-02 |
| Normal-vs-Obese |
2.793100E-04 |
| Normal-vs-Extreme_Obese |
1.834820E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.108600E-01 |
| Normal_Weight-vs-Obese |
7.309900E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.471000E-01 |
| Extreme_Weight-vs-Obese |
1.329560E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.940000E-01 |
| Obese-vs-Extreme_Obese |
4.492000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.330100E-02 |
| Normal-vs-Age(41-60Yrs) |
8.50659999995784E-07 |
| Normal-vs-Age(61-80Yrs) |
2.460100E-02 |
| Normal-vs-Age(81-100Yrs) |
4.199400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.352000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.642000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.020700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.681400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.260070E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.694020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.85310000069927E-08 |
| Normal-VS-Type2 PRCC |
9.143400E-01 |
| Normal-VS-KIRP CIMP |
1.361040E-01 |
| Normal-VS-Unclassified PRCC |
4.068000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.72279999991021E-07 |
| Type1 PRCC-VS-KIRP CIMP |
9.904600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.200400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.297570E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.073900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.916400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.786800E-01 |
| Normal-vs-N1 |
8.384200E-02 |
| Normal-vs-N2 |
3.677800E-01 |
| N0-vs-N1 |
1.589040E-01 |
| N0-vs-N2 |
4.560000E-01 |
| N1-vs-N2 |
2.672200E-01 |
|
|
